文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

脂肪源干细胞共培养抑制增生性瘢痕成纤维细胞的病理表型。

Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.

机构信息

Department of Plastic and Reconstructive Surgery, Shanghai Tissue Engineering Key Laboratory, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai, P.R. China .

出版信息

Tissue Eng Part A. 2018 Mar;24(5-6):382-393. doi: 10.1089/ten.TEA.2016.0550. Epub 2017 Jul 3.


DOI:10.1089/ten.TEA.2016.0550
PMID:28562226
Abstract

Hypertrophic scar (HS) is a dermal fibroproliferative disease characterized by fibroblast over-proliferation, overproduction, and deposition of the extracellular matrix. Growing evidence demonstrated that adipose-derived stem cells (ASCs) secrete a plethora of trophic and antifibrotic factors, which suppress inflammation and ameliorate fibrosis of different tissues. However, few studies investigate their effect on repressing HS activity. This study evaluated the suppressing effect of ASCs on HS fibroblast bioactivity and the possible mechanism via a coculture model. HS-derived fibroblasts (HSFs) and ASCs were isolated from individual patients. HSFs or HSFs treated with transforming growth factor-β1 (TGF-β1) were cocultured with ASCs and the change of HSF cellular behaviors, such as cell proliferation, migration, contractility, and gene/protein expression of scar-related molecules, were evaluated by cell counting assay, cell cycle analysis, scratch wound assay, fibroblast-populated collagen lattice (FPCL) contractility assay, real-time quantitative polymerase chain reaction, ELISA, and western blotting assay. After 5 days of ASC coculture treatment, the expression levels of collagen I (Col 1), collagen III (Col 3), fibronectin (FN), TGF-β1, interleukin-6 (IL-6), interleukin-8 (IL-8), connective tissue growth factor (CTGF), and alpha-smooth muscle actin (α-SMA) in HSFs decreased significantly while the expression levels of decorin (DCN) and MMP-1/TIMP-1 (matrix metalloproteinase/tissue inhibitor of MMP) ratio increased significantly. Besides, after 5 days of exogenous TGF-β1 stimulation, the expression levels of Col 1, FN, TGF-β1, IL-6, CTGF, and α-SMA in HSFs increased significantly. Impressively, all these increased gene expression levels were reversed by 5 days of ASCs coculture treatment. Additionally, the proliferation, migration, and contractility of HSFs were all significantly reduced by ASC coculture treatment. Furthermore, the protein levels of TGF-β1 and intracellular signal pathway-related molecules, such as p-smad2, p-smad3, p-Stat3, and p-ERK, were downregulated significantly in HSFs after 5 days of ASCs coculture treatment. This study demonstrated that coculture of HSFs with ASCs not only inhibited proliferation, migration, and contractility of HSFs but also decreased the expression levels of HSF-related or TGF-β1-induced molecules. Additionally, the antifibrotic effect on HSFs was likely mediated by the inhibition of multiple intracellular signaling. The results of this study suggest the therapeutic potential of ASCs for HS treatment, which is worth of further investigation.

摘要

增生性瘢痕(HS)是一种以成纤维细胞过度增殖、过度产生和细胞外基质沉积为特征的真皮纤维增生性疾病。越来越多的证据表明,脂肪来源的干细胞(ASCs)分泌大量的营养和抗纤维化因子,抑制炎症,改善不同组织的纤维化。然而,很少有研究探讨它们对抑制 HS 活性的影响。本研究通过共培养模型评估了 ASCs 对 HS 成纤维细胞生物活性的抑制作用及其可能的机制。从个体患者中分离出 HS 衍生的成纤维细胞(HSFs)和 ASCs。用转化生长因子-β1(TGF-β1)处理 HSFs 后,与 ASCs 共培养,并通过细胞计数法、细胞周期分析、划痕实验、成纤维细胞填充胶原晶格(FPCL)收缩实验、实时定量聚合酶链反应、酶联免疫吸附测定和 Western blot 检测 HSF 细胞行为的变化,如细胞增殖、迁移、收缩和瘢痕相关分子的基因/蛋白表达。经过 5 天的 ASC 共培养处理后,HSFs 中胶原 I(Col1)、胶原 III(Col3)、纤维连接蛋白(FN)、转化生长因子-β1(TGF-β1)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、结缔组织生长因子(CTGF)和α-平滑肌肌动蛋白(α-SMA)的表达水平显著降低,而聚集蛋白聚糖(DCN)和基质金属蛋白酶/组织抑制剂 MMP(MMP-1/TIMP-1)的表达水平显著升高。此外,在 5 天的外源性 TGF-β1 刺激后,HSFs 中 Col1、FN、TGF-β1、IL-6、CTGF 和α-SMA 的表达水平显著升高。令人印象深刻的是,所有这些增加的基因表达水平在 5 天的 ASC 共培养处理后都被逆转。此外,HSFs 的增殖、迁移和收缩能力均显著降低。此外,在 5 天的 ASC 共培养处理后,HSFs 中的 TGF-β1 和细胞内信号通路相关分子,如 p-smad2、p-smad3、p-Stat3 和 p-ERK 的蛋白水平显著下调。本研究表明,HSFs 与 ASCs 共培养不仅抑制了 HSFs 的增殖、迁移和收缩,还降低了 HSF 相关或 TGF-β1 诱导的分子的表达水平。此外,对 HSFs 的抗纤维化作用可能是通过抑制多种细胞内信号通路介导的。本研究结果提示 ASCs 治疗 HS 具有潜在的治疗作用,值得进一步研究。

相似文献

[1]
Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.

Tissue Eng Part A. 2017-7-3

[2]
Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.

J Dermatol Sci. 2016-8

[3]
Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.

Chem Biol Drug Des. 2023-10

[4]
Gallic acid attenuates TGF-β1-stimulated collagen gel contraction via suppression of RhoA/Rho-kinase pathway in hypertrophic scar fibroblasts.

Life Sci. 2016-9-15

[5]
Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.

Exp Dermatol. 2015-5

[6]
Umbilical cord-derived mesenchymal stem cells exert anti-fibrotic action on hypertrophic scar-derived fibroblasts in co-culture by inhibiting the activation of the TGF β1/Smad3 pathway.

Exp Ther Med. 2021-3

[7]
Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway.

Stem Cell Res Ther. 2016-8-2

[8]
Hepatocyte Growth Factor Secreted from Human Adipose-Derived Stem Cells Inhibits Fibrosis in Hypertrophic Scar Fibroblasts.

Curr Mol Med. 2020

[9]
Wnt4 negatively regulates the TGF-β1-induced human dermal fibroblast-to-myofibroblast transition via targeting Smad3 and ERK.

Cell Tissue Res. 2019-11-27

[10]
ALA-PDT promotes the death and contractile capacity of hypertrophic scar fibroblasts through inhibiting the TGF-β1/Smad2/3/4 signaling pathway.

Photodiagnosis Photodyn Ther. 2024-2

引用本文的文献

[1]
Adipose-derived Stem Cells for Treatment of Diabetic Foot Ulcers: A Review.

Curr Stem Cell Res Ther. 2025

[2]
Adipose-Derived Stem Cell Products and Combination Therapies for the Treatment of Pathological Scars: A Review of Current Preclinical and Clinical Studies.

Clin Cosmet Investig Dermatol. 2025-5-27

[3]
Adipose-Derived Stem Cell Therapy in Hypertrophic and Keloid Scars: A Systematic Review of Experimental Studies.

Plast Surg (Oakv). 2025-5

[4]
Effectiveness and Safety of Micro-Plasma Radiofrequency Treatment Combined With Autologous Chyle Fat Grafting Treatment for Hypertrophic Scars: A Retrospective Study.

J Cosmet Dermatol. 2025-1

[5]
Stem cell-based therapy for fibrotic diseases: mechanisms and pathways.

Stem Cell Res Ther. 2024-6-18

[6]
Type I collagen and fibromodulin enhance the tenogenic phenotype of hASCs and their potential for tendon regeneration.

NPJ Regen Med. 2023-12-14

[7]
Advancements in adipose-derived stem cell therapy for skin fibrosis.

World J Stem Cells. 2023-5-26

[8]
Cross talk of vasopressin conditioned cell therapy in ischemic heart disease: Role of oxidative stress markers.

Iran J Basic Med Sci. 2022-9

[9]
Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases.

Acta Pharm Sin B. 2022-4

[10]
Knockdown of lncRNA-NEAT1 expression inhibits hypoxia-induced scar fibroblast proliferation through regulation of the miR-488-3p/COL3A1 axis.

Exp Ther Med. 2022-5-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索